SCHEMBL7956235

SCHEMBL7956235

CCOC(=O)c1cc2c(C)ccc3c2n1CCC3OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.40
DRD3 P35462 2/20 0.39
F10 P00742 1/20 0.38
ALDH1A1 P00352 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 2/20 0.37
MEN1 O00255 1/20 0.37
PKM P14618 1/20 0.36
GAA P10253 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
KDM4E B2RXH2 3/20 0.35
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35
RAB9A P51151 1/20 0.35
HSD17B10 Q99714 2/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
TSHR P16473 1/20 0.35
RECQL P46063 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7957916 0.87 DRD3 (0.40) KMT2ADRD3F10ALDH1A1SMN1; SMN2
SCHEMBL7954495 0.83 ALDH1A1 (0.40) KMT2AALDH1A1SMN1; SMN2LMNAMEN1
SCHEMBL7954146 0.76 KDM4E (0.41) KMT2ADRD3ALDH1A1SMN1; SMN2LMNA
SCHEMBL7954102 0.75 MAPK1 (0.54) KMT2AALDH1A1LMNAMEN1GAA
SCHEMBL7955905 0.75 F10 (0.32) F10
SCHEMBL7955774 0.74 MAPK1 (0.43) KMT2AALDH1A1SMN1; SMN2LMNAMEN1
SCHEMBL7955908 0.74
SCHEMBL7957927 0.74 MCL1 (0.43) KMT2AALDH1A1SMN1; SMN2LMNAMEN1
SCHEMBL7954130 0.74 ALDH1A1 (0.45) KMT2AALDH1A1SMN1; SMN2LMNAMEN1
SCHEMBL7955863 0.71 ALDH1A1 (0.41) KMT2AALDH1A1SMN1; SMN2LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6271251-B1 CARDIOVASCULAR DISORDERS SUMITOMO PHARMACEUTICALS COMPANY LIMITED (JP) 2001-08-07 US disclosed
US-5977100-A Substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1999-11-02 US disclosed
US-5834454-A TREATMENT OF ANGINA, ISCHEMIA, ARRHYTHMIA SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1998-11-10 US disclosed
EP-0787728-A1 Substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1997-08-06 EP disclosed